Houston-based medical device company Procyrion, Inc. has been particularly active in biotech news in 2014, having announced a new scientific advisory board in January, followed by news that the company had been awarded $1.5 million in state funding from the Texas Emerging Technology Fund, and was recognized by the Rice Alliance as a “Top Life Science Company” for its Aortix™ medical device. As buzz about Procyrion and its novel Aortix device continues to gain momentum in the medical marketplace, the company has now announced that it will present its catheter-deployed circulatory assist device at the American College of Cardiology 63rd Annual Scientific Session and Expo (ACC.14) scheduled for March 29–31 in Washington D.C.
